Segueix
Dr. Pere Fontova Palé
Dr. Pere Fontova Palé
PostDoc Researcher, Universitat de Barcelona
Correu electrònic verificat a ub.edu
Títol
Citada per
Citada per
Any
TGF‐β1 targets Smad, p38 MAPK, and PI 3K/Akt signaling pathways to induce PFKFB 3 gene expression and glycolysis in glioblastoma cells
A Rodríguez‐García, P Samsó, P Fontova, H Simon‐Molas, A Manzano, ...
The FEBS Journal 284 (20), 3437-3454, 2017
1422017
Online haemodiafiltration improves inflammatory state in dialysis patients: a longitudinal study
I Rama, I Llaudo, P Fontova, G Cerezo, C Soto, C Javierre, M Hueso, ...
PLoS One 11 (10), e0164969, 2016
262016
PI3K–Akt signaling controls PFKFB3 expression during human T-lymphocyte activation
H Simon-Molas, C Arnedo-Pac, P Fontova, A Vidal-Alabro, E Castaño, ...
Molecular and Cellular Biochemistry 448, 187-197, 2018
252018
Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of …
C El Haj, O Murillo, A Ribera, N Lloberas, J Gómez-Junyent, F Tubau, ...
International journal of antimicrobial agents 51 (6), 854-861, 2018
242018
Donor/recipient HLA molecular mismatch scores predict primary humoral and cellular alloimmunity in kidney transplantation
M Meneghini, E Crespo, M Niemann, A Torija, N Lloberas, V Pernin, ...
Frontiers in immunology 11, 623276, 2021
202021
Influence of the circadian timing system on tacrolimus pharmacokinetics and pharmacodynamics after kidney transplantation
P Fontova, H Colom, R Rigo-Bonnin, LN Van Merendonk, A Vidal-Alabro, ...
Frontiers in Pharmacology 12, 636048, 2021
182021
The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis
J Guiteras, É Ripoll, N Bolaños, L De Ramon, P Fontova, N Lloberas, ...
Molecular Therapy-Nucleic Acids 24, 807-821, 2021
102021
TGF-b1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells
A Rodrıguez-Garcıa, P Samsó, P Fontova, H Simon-Molas, A Manzano, ...
FEBS J 284 (20), 3437-54, 2017
92017
Sustained Inhibition of Calcineurin Activity With a Melt‐Dose Once‐daily Tacrolimus Formulation in Renal Transplant Recipients
P Fontova, H Colom, R Rigo‐Bonnin, O Bestard, A Vidal‐Alabró, ...
Clinical Pharmacology & Therapeutics 110 (1), 238-247, 2021
82021
Measurement of calcineurin activity in peripheral blood mononuclear cells by ultra-high performance liquid chromatography-tandem mass spectrometry. Renal transplant recipients …
P Fontova, R Rigo-Bonnin, A Vidal-Alabro, G Cerezo, O Bestard, ...
Clinica Chimica Acta 495, 287-293, 2019
72019
ANRIL as a genetic marker for cardiovascular events in renal transplant patients – an observational follow‐up cohort study
A Arbiol‐Roca, A Padró‐Miquel, A Vidal‐Alabró, M Hueso, P Fontova, ...
Transplant International 31 (9), 1018-1027, 2018
62018
Dual and opposite costimulatory targeting with a novel human fusion recombinant protein effectively prevents renal warm ischemia reperfusion injury and allograft rejection in …
J Guiteras, L De Ramon, E Crespo, N Bolaños, S Barcelo-Batllori, ...
International Journal of Molecular Sciences 22 (3), 1216, 2021
52021
A novel late-stage autophagy inhibitor that efficiently targets lysosomes inducing potent cytotoxic and sensitizing effects in lung cancer
A Molero-Valenzuela, P Fontova, D Alonso-Carrillo, I Carreira-Barral, ...
Cancers 14 (14), 3387, 2022
42022
TP53-induced glycolysis and apoptosis regulator (TIGAR) is upregulated in lymphocytes stimulated with concanavalin A
H Simon-Molas, X Vallvé-Martínez, I Caldera-Quevedo, P Fontova, ...
International Journal of Molecular Sciences 22 (14), 7436, 2021
42021
Mycophenolic acid interferes the transcriptional regulation and protein trafficking of maturation surface markers in dendritic cells
P Fontova, I Rama, I Llaudó, A Vidal-Alabró, G Cerezo, A Manzano, ...
International Immunopharmacology 91, 107025, 2021
42021
Validation and evaluation of four sample preparation methods for the quantification of intracellular tacrolimus in peripheral blood mononuclear cells by UHPLC-MS/MS
LN van Merendonk, P Fontova, R Rigo-Bonnin, H Colom, A Vidal-Alabró, ...
Clinica Chimica Acta 503, 210-217, 2020
42020
A potent fluorescent transmembrane HCl transporter perturbs cellular pH and promotes cancer cell death
M Fares, X Wu, DA McNaughton, AM Gilchrist, W Lewis, PA Keller, ...
Organic & Biomolecular Chemistry 21 (12), 2509-2515, 2023
32023
Dual costimulatory and coinhibitory targeting with a hybrid fusion protein as an immunomodulatory therapy in lupus nephritis mice models
J Guiteras, E Crespo, P Fontova, N Bolaños, M Gomà, E Castaño, ...
International Journal of Molecular Sciences 23 (15), 8411, 2022
32022
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction
N Lloberas, JM Grinyó, H Colom, A Vidal-Alabró, P Fontova, ...
Kidney International 104 (4), 840-850, 2023
22023
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate-and Extended-Release Tacrolimus Formulations
P Fontova, LN van Merendonk, A Vidal-Alabró, R Rigo-Bonnin, G Cerezo, ...
Pharmaceutics 15 (5), 1481, 2023
22023
En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.
Articles 1–20